bosutinib tablets
for oral use Initial U.S. Approval: XXXX

Bosulif (bosutinib) is a medication used for the treatment of chronic myeloid leukaemia (CML) in adults with the Philadelphia chromosome (Ph+). It is used to treat adult patients with newly-diagnosed chronic phase Ph+ chronic myelogenous leukemia (CML) or with chronic, accelerated, or blast phase Ph+ CML with resistance or intolerance to prior therapy.

Facts about bosutinib-tablets

DISEASE INDICATIONS-Leukemia
MANUFACTURER-Pfizer Limited
USAGE-Tablets: 100 mg and 500 mg
MEDICINE APPROVED BY-European Medical Agency (EMA),Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “sotorasib tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.